Testing an eye drop for worsening glaucoma
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old.
- Have primary open-angle glaucoma in at least one eye (the study eye).
- Have glaucoma progression confirmed by visual field testing.
- Have a visual field mean deviation between -3 and -16 dB in the study eye.
- Have adequate visual acuity and meet refraction or axial length criteria in the study eye.
- Have eye pressure between 10 and 21 mmHg in the study eye.
- Be willing to use contraception if applicable and not plan pregnancy or sperm/egg donation during the study.
- Be able to attend study visits and follow instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
This study tests whether insulin eye drops can help people with glaucoma by protecting the optic nerve. It is an early-stage trial that may offer a new way to manage the condition.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
This study tests a new eye drop against an existing one to see which better lowers eye pressure in people with open-angle glaucoma or ocular hypertension. You may be able to join if you have high eye pressure in both eyes that needs treatment and you are at least 18 years old.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.